PPT-Pre-exposure Prophylaxis for HIV Prevention

Efficacy and the importance of adherence Joanne Stekler MD MPH August 20 2015 Key HIV PrEP Trials Using Oral Tenofovir TDF or TenofovirEmtricitabine TDFFTC Study Study Population. Dr.. Rachel Baggaley, HIV dept. WHO, Geneva. GNP+ . WEBINAR: What does PrEP mean for. people living with HIV: science, policy. and . implementation?. . Date: Thursday, 30th July 2015. Time: 4pm CET. for HIV PreventionMay 2014Fast Facts Pre-exposure prophylaxis, or PrEP, is a way to help prevent HIV by taking a pill every day. People who are at substantial risk for HIV should talk to their doctor PrEP Information Sheet Pre-exposure Prophylaxis (PrEP) for HIV Prevention Frequently Asked Questions What is PrEP? “PrEP” stands for preexposure prophylaxis. The word “prophylaxis” PrEP. ). Yuma Health District 5/23/16. Alyssa Guido, MPH. Program Director, Arizona AETC. Arizona AIDS Education and Training Center. This . project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under . Kevin L. Ard, MD, MPH. October 20, 2016. Learning objectives. Summarize the indications for and management of pre- and post-exposure prophylaxis. Understand clinical uncertainties in pre-exposure prophylaxis management. Integrating Pre-Exposure Prophylaxis ( PrEP ) into the Primary Care Setting Christine Kerr, MD Medical Director of HIV, Hepatitis, and Specialty Care Hudson River HealthCare February 12, 2016 Why Group exercises. IAEA . Training. . C. ourse. Prevention of accidental exposure in radiotherapy. 2. Group exercise 1. Group Exercise G1. : . BSS. Was the BSS known in your institution . (truth!). ?. 1of 2PageCreated 9/2019ecommendations for Persons Exposed to MeaslesaIG can be administered intramuscularly IGIM or intravenously IGIV Please check references available at https//wwwcdcgov/measles/ind NURS RESEARCH POROJECT PROPOSA. NURS 503. Name:…………. Ana G Mendez University. Facilitator: Nancy Woelki . DNP, APRN, MSN, RN. Date:………... The purpose of this research was to evaluate the advantage and disadvantage using of PrEP for HIV-negative adults with high risk for HIV.. Geneva 2019. Dr Venkatraman Chandra-Mouli. DEFINITIONS . Human immunodeficiency virus (HIV): . A virus that targets the immune system & weakens the body’s defense system against infections. . Antiretroviral medicines (ARVs): . Facilitator Background Materials. Review these slides prior to using these materials. Introduction to Training Materials. These training materials . May need to be modified for use if national guidelines do not align with WHO guidance as of March 2022. rapid progressive & highly fatal viral disease of CNS caused by Lyssavirus type 1. .. Zoonotic . disease of warm blooded animals (dogs, cats , bats, racoons, skunks, foxes ) . Transmitted . to man by bite of rabid animal. Courses in Therapeutics and Disease State Management. Learning Objectives (Slide 1 of 3). Differentiate between influenza A and influenza B. List the primary subtypes of influenza A that are currently circulating. , PEP, PREP . Compiled by Jason Vermaak, . Ektha. . govind. and . Anjana. Thomas. Opportunistic infection In HIV. Opportunistic infections are those that occur more frequently in immunocompromised populations and are often more clinically severe in this group of people..